“INVESTIGATION OF MODIFIED SORAFENIB DERIVATIVES AS A TYROSINE KINASE INHIBITORS OF LEUKIMIA VIA MOLECULAR DOCKING”. Frontier in Medical and Health Research, vol. 4, no. 5, May 2026, pp. 567-85, https://fmhr.net/index.php/fmhr/article/view/2904.